PRNewswire - Techseriesinsight

November 25, 2024
PRNewswire
Healthcare

Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug Administration (FDA) approval of a label expansion into biliary tract cancer (BTC) for the PATHWAY® anti-HER2/neu (4B5) Rabbit Monoclonal...

November 25, 2024
PRNewswire
Biotechnology

J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy

J INTS BIO announced research findings on its innovative brain tumor treatment, ‘JIN-001,’ developed in collaboration with MD Anderson Cancer Center, at the 2024 Society of Neuro-Oncology (SNO) Annual Meeting in Texas,...

November 25, 2024
PRNewswire
Artificial Intelligence

Simply Contact Leverages AI in Customer Support to Transform CX

Advances in AI customer service are transforming the way businesses deliver support, creating smoother and more personalized customer experiences. Simply Contact, an award-winning outsourcing leader, uses AI-powered tools to...

November 22, 2024
PRNewswire
Business Broadcast

At Its European Innovation Day 2024, Huawei Advocates Collaboration to Unlock Europe’s Potential

Huawei hosted the 2024 “Europe Innovation Day” in Paris, an event where European tech leaders, business representatives, and innovation experts explored opportunities for cross-border and cross-industry collaboration. Under this year’s...

November 22, 2024
PRNewswire
Artificial Intelligence

Delta Attended COP29 for the 17th Consecutive Time, Focusing on AI Datacenter Energy Efficiency and Net-Zero Buildings

Delta marked its 17th consecutive participation in the 29th United Nations Climate Change Conference (UNFCCC COP29) held in Baku, Azerbaijan. This year, Delta co-hosted a side event on 21st with the American...

November 22, 2024
PRNewswire
Networking

Meet the 8849 TANK Pad: The World’s First 5G Rugged Projector Tablet

Today, we are excited to announce our latest invention – 8849 Tank Pad, the world’s first 5G rugged projector tablet. It’s built to withstand extreme environments, ensuring uncompromising performance...

November 22, 2024
PRNewswire
Healthcare

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs™ Trauma Products in the U.S....

November 22, 2024
PRNewswire
Biotechnology

FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for...

November 22, 2024
PRNewswire
Press Release

China Matters’ Feature: How High-Quality Development Is Shaping China’s Future

China has entered a transformative phase in its economic evolution, prioritizing sustainability and innovation over rapid growth. This strategic shift, known as high-quality development, represents a fundamental change aimed...

November 21, 2024
PRNewswire
Biotechnology

Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans

Vicebio Ltd (“Vicebio”), a biopharmaceutical company pioneering next-generation vaccines for life-threatening respiratory viruses, today announces its progress in the ongoing VXB-241 bivalent RSV-hMPV Phase 1 (P1) study as well as...